Gene expression markers for response to EGFR inhibitor drugs

Details for Australian Patent Application No. 2004211955 (hide)

Owner Genomic Health, Inc. Cedars-Sinai Medical Center

Inventors Baker, Joffre B.; Shak, Steve; Cronin, Maureen T.; Agus, David

Agent Griffith Hack

Pub. Number AU-B-2004211955

PCT Pub. Number WO2004/071572

Priority 60/445,968 06.02.03 US

Filing date 5 February 2004

Wipo publication date 26 August 2004

Acceptance publication date 14 May 2009

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

25 August 2005 PCT application entered the National Phase

  PCT publication WO2004/071572 Priority application(s): WO2004/071572

14 May 2009 Application Accepted

  Published as AU-B-2004211955

10 September 2009 Standard Patent Sealed

1 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004211957-Low profile spinal fixation system

2004211949-RNAi targeting of viruses